European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

Journal article


Publication Details

Author(s): Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Olesen AB, Foeldvari I, Frances C, Jalili A, Just U, Kahari V, Karpati S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkoetter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T
Journal: Journal of the European Academy of Dermatology and Venereology
Publication year: 2017
Volume: 31
Journal issue: 9
Pages range: 1401-1424
ISSN: 0926-9959


Abstract

The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, current strategies in the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum.


FAU Authors / FAU Editors

Sticherling, Michael Prof. Dr.
Professur für Dermatologie


External institutions with authors

Aarhus University Hospital / Aarhus Universitetshospital
Autonomous University of Barcelona (UAB) / Universitat Autònoma de Barcelona
Azienda Socio Sanitaria Territoriale (ASST) Lecco
Charité - Universitätsmedizin Berlin
Copenhagen University Hospital
Helsingin yliopisto / University of Helsinki
Hôpital Cochin
Hôpitaux Universitaires Saint-Louis, Lariboisière, Fernand-Widal
Institut national de physique nucléaire et de physique des particules (IN2P3)
Kantonsspital St.Gallen
Medical University of Lublin / Uniwersytet Medyczny w Lublinie
Medizinische Universität Wien
Private Universität Witten/Herdecke gGmbH
Royal Free Hospital
Schön Klinik Hamburg Eilbek
Semmelweis University
Turku University Hospital / Turun yliopistollinen keskussairaala (TYKS)
Università degli Studi di Cagliari
Università Politecnica delle Marche (UNIVPM)
Universitätsklinikum Halle (Saale)
Universitätsklinikum Köln
University College London (UCL)
University Hospital Ghent
University of Genova / Università degli Studi di Genova
University of Paris 6 - Pierre et Marie Curie / Université Paris VI Pierre et Marie Curie (UPMC)
University of Turin / Università degli Studi di Torino (UNITO)
Wrocław Medical University / Uniwersytet Medyczny we Wrocławiu


How to cite

APA:
Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L.,... Krieg, T. (2017). European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. Journal of the European Academy of Dermatology and Venereology, 31(9), 1401-1424. https://dx.doi.org/10.1111/jdv.14458

MLA:
Knobler, R., et al. "European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes." Journal of the European Academy of Dermatology and Venereology 31.9 (2017): 1401-1424.

BibTeX: 

Last updated on 2018-16-11 at 02:08